ArticleOncoimmunology

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma.

Elisa Brandetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.